U.S. Markets open in 4 hrs 48 mins

uniQure N.V. (QURE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
37.87-0.35 (-0.92%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close38.22
Bid37.13 x 800
Ask39.00 x 900
Day's Range37.40 - 38.29
52 Week Range25.80 - 52.19
Avg. Volume578,609
Market Cap1.739B
Beta (5Y Monthly)1.21
PE Ratio (TTM)N/A
EPS (TTM)-3.10
Earnings DateJul 28, 2021 - Aug 02, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est66.93
  • Investopedia

    Top Biotech Stocks for Q4 2021

    The biotechnology industry includes companies that develop drugs and diagnostic technologies for the treatment of diseases and medical conditions. This means that investors may wait for years before knowing whether a drug under development will pay off. Many biotech companies have shifted their focus entirely or added COVID-19 vaccine and treatments to their product pipeline.

  • Simply Wall St.

    These 4 Measures Indicate That uniQure (NASDAQ:QURE) Is Using Debt Safely

    Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

  • GlobeNewswire

    uniQure to Participate in Multiple Upcoming Industry Conferences in September

    LEXINGTON, Mass. and AMSTERDAM, Sept. 07, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming investor and scientific conferences: Citi’s 16th Annual BioPharma Virtual Conference, September 8 - 10, 2021 Members of uniQure’s management team, including Matt Kapusta, chief executive officer, will participate in virtual one-on-one inv